During the past decade, Giuseppe De Luca conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Giuseppe De Luca" are "Coronary Angioplasty" (1 trials) and "ST Elevated Myocardial Infarction Undergoing Mechanical Reperfusion" (1 trials). Many other conditions were trialed in "Giuseppe De Luca" in a lesser frequency.

Most popular intervention types in "Giuseppe De Luca" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Adenosine" (1 trials), "Percutaneous Coronary Revascularization for STEMI" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Giuseppe De Luca" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Giuseppe De Luca". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Giuseppe De Luca, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Giuseppe De Luca, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".